This meta-analysis aimed to evaluate the comparative diagnostic accuracy of [18F]FDG PET/CT versus [18F]FDG PET/MRI in identifying lymph node metastases in individuals with nasopharyngeal carcinoma.
A comprehensive search was executed across PubMed, Embase, and Web of Science through September 2023 to identify studies evaluating the diagnostic precision of [18F]FDG PET/CT and [18F]FDG PET/MRI in detecting lymph node metastasis in nasopharyngeal carcinoma. Sensitivity and specificity were assessed through the DerSimonian-Laird method, incorporating the Freeman-Tukey transformation.
The meta-analysis encompassed nine articles, involving a total of 916 patients. The overall sensitivity and specificity of [18F]FDG PET were 0.95 (95%CI: 0.88–1.00) and 0.95 (95%CI: 0.84–1.00). The overall sensitivity of [18F]FDG PET/CT was 0.94 (95%CI, 0.85–0.99), whereas [18F]FDG PET/MRI achieved a sensitivity of 1.00 (95%CI, 0.94–1.00). The findings reveal that [18F]FDG PET/CT demonstrates comparable sensitivity to [18F]FDG PET/MRI (
[18F]FDG PET demonstrates high sensitivity and specificity in identifying lymph node metastasis in nasopharyngeal carcinoma. Furthermore, [18F]FDG PET/CT exhibits comparable sensitivity and specificity to [18F]FDG PET/MRI.